• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Muc1、p63蛋白在甲状腺乳头状癌弥漫硬化型及传统型中的表达及临床意义]

[Expression and clinical significance of Muc1, p63 protein in diffuse sclerosing variant of papillary thyroid carcinoma and conventional papillary thyroid carcinoma].

作者信息

Hao Yalin, Jin Cheng, Wang Jiadong

机构信息

Department of Otolaryngology-Head and Neck Surgery, Renji Hospital, Medical College of Shanghai Jiao Tong University,Shanghai, 200001, China.

出版信息

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 May;27(9):457-61.

PMID:23898609
Abstract

OBJECTIVE

To investigate the expression and clinical significance of Muc1, p63 protein in diffuse sclerosing variant of papillary thyroid carcinoma and conventional papillary thyroid carcinoma.

METHOD

Immunohistochemistry (SP) was used to detect the expressions of Muc1, p63 protein in 30 samples of DSVPTC (experiment group) and 30 samples of CPTC (control group). Patients in two groups were matched in age, gender, tumor side, tumor size and date of diagnosis.

RESULT

(1) The positive rate of Muc1 in DSVPTC and CPTC was 76.67% (23/30) and 53.33% (16/30) respectively, immunohistochemical staining expressed as brown or tan particles in the membrane or the cytoplasm,with a significant difference between the two groups (P < 0.05). The positive rate of p63 in DSVPTC and CPTC was 80% (24/30) and 43.33% (13/30) respectively, immunohistochemical staining expressed as a brown or tan particles in the muclei,with a significant difference between the two groups (P < 0.05). (2) Cervical lymph node metastasis rate in DSVPTC and CPTC was 50% (15/30) and 20% (6/30) respectively, with a significant difference between the two groups (P < 0.05). (3) In All cases,the positive rate of Muc1 in cervical lymph node metastasis group (21 cases) and without metastasis group (39 cases) was 85.71% (18/21) and 53.85% (21/39) respectively,with a significant difference between the two groups (P < 0.05); the positive rate of p63 was 95.24% (20/21) and 43.59% (17/39) respectively,with a significant difference between the two groups (P < 0.01). (4) Spearman rank correlation analysis showed that expression of Muc1 and p63 were positively correlated in both groups(r = 0.530,0. 386, P < 0.05).

CONCLUSION

(1) There are high expression of Muc1 and p63 protein in DSVPTC, and relatively low expression in CPTC, DSVPTC have a higher rate of cervical lymph node metastasis at the time of being diagnosed, compared to the CPTC. These results show that DSVPTC is a more biologically aggressive variant of the PTC. (2) Abnormal expression of Muc1 and p63 may be important to promote the progression and metastasis of PTC, thus they can be used as predictors of malignant behavior in PTC. (3) Muc1 and p63 may be synergistically promote proliferation and invasion metastasis of the PTC malignant cell.

摘要

目的

探讨Muc1、p63蛋白在甲状腺乳头状癌弥漫硬化型(DSVPTC)及传统甲状腺乳头状癌(CPTC)中的表达及临床意义。

方法

采用免疫组织化学(SP)法检测30例DSVPTC标本(实验组)及30例CPTC标本(对照组)中Muc1、p63蛋白的表达。两组患者在年龄、性别、肿瘤部位、肿瘤大小及诊断日期方面相匹配。

结果

(1)DSVPTC和CPTC中Muc1的阳性率分别为76.67%(23/30)和53.33%(16/30),免疫组化染色表现为细胞膜或细胞质内的棕色或棕褐色颗粒,两组间差异有统计学意义(P<0.05)。DSVPTC和CPTC中p63的阳性率分别为80%(24/30)和43.33%(13/30),免疫组化染色表现为细胞核内的棕色或棕褐色颗粒,两组间差异有统计学意义(P<0.05)。(2)DSVPTC和CPTC的颈部淋巴结转移率分别为50%(15/30)和20%(6/30),两组间差异有统计学意义(P<0.05)。(3)所有病例中,颈部淋巴结转移组(21例)和无转移组(39例)中Muc1的阳性率分别为85.71%(18/21)和53.85%(21/39),两组间差异有统计学意义(P<0.05);p63的阳性率分别为95.24%(20/21)和43.59%(17/39),两组间差异有统计学意义(P<0.01)。(4)Spearman等级相关分析显示,两组中Muc1和p63的表达均呈正相关(r=0.530,0.386,P<0.05)。

结论

(1)DSVPTC中Muc1和p63蛋白表达较高,CPTC中表达相对较低,与CPTC相比,DSVPTC在诊断时颈部淋巴结转移率更高。这些结果表明DSVPTC是PTC中生物学行为更具侵袭性的变异型。(2)Muc1和p63的异常表达可能对PTC的进展和转移起重要作用,因此可作为PTC恶性行为的预测指标。(3)Muc1和p63可能协同促进PTC恶性细胞的增殖和侵袭转移。

相似文献

1
[Expression and clinical significance of Muc1, p63 protein in diffuse sclerosing variant of papillary thyroid carcinoma and conventional papillary thyroid carcinoma].[Muc1、p63蛋白在甲状腺乳头状癌弥漫硬化型及传统型中的表达及临床意义]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 May;27(9):457-61.
2
Diffuse sclerosing variant of papillary thyroid carcinoma--an update of its clinicopathological features and molecular biology.弥漫硬化型甲状腺乳头状癌——其临床病理特征和分子生物学的最新研究进展。
Crit Rev Oncol Hematol. 2015 Apr;94(1):64-73. doi: 10.1016/j.critrevonc.2014.12.001. Epub 2014 Dec 18.
3
[Expression of mucin-l and beta-catenin in papillary thyroid carcinoma and the clinical significance thereof].[黏蛋白-1和β-连环蛋白在甲状腺乳头状癌中的表达及其临床意义]
Zhonghua Yi Xue Za Zhi. 2009 Feb 17;89(6):393-6.
4
[The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].[三叶因子3及SDF-1/CXCR4生物学轴在甲状腺乳头状癌中的表达及意义]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Jan;28(2):108-12.
5
MUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapse.甲状腺乳头状癌中MUC1的表达与BRAF突变及淋巴结转移相关;后者是复发的最重要危险因素。
Thyroid. 2014 Sep;24(9):1375-84. doi: 10.1089/thy.2013.0594. Epub 2014 Aug 1.
6
Sonographic characteristics of diffuse sclerosing variant of papillary thyroid carcinoma with histopathological correlation: a preliminary study.超声表现特征与弥漫硬化型甲状腺乳头状癌的组织病理学相关性:初步研究。
Orphanet J Rare Dis. 2024 Mar 26;19(1):136. doi: 10.1186/s13023-023-02867-3.
7
Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis.弥漫性硬化型乳头状甲状腺癌的预后意义:一项系统评价和荟萃分析。
Eur J Endocrinol. 2017 Apr;176(4):433-441. doi: 10.1530/EJE-16-0863.
8
Expression of decoy receptor 3 in diffuse sclerosing variant of papillary thyroid carcinoma: correlation with M2 macrophage differentiation and lymphatic invasion.在弥漫硬化型甲状腺乳头状癌中诱饵受体 3 的表达:与 M2 巨噬细胞分化和淋巴侵袭的相关性。
Thyroid. 2013 Jun;23(6):720-6. doi: 10.1089/thy.2012.0261. Epub 2013 May 28.
9
Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker.甲状腺乳头状癌的全基因组分析确定MUC1为独立的预后标志物。
Cancer Res. 2004 Jun 1;64(11):3780-9. doi: 10.1158/0008-5472.CAN-03-1460.
10
A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases.弥漫硬化型甲状腺乳头状癌:34 例连续病例的临床病理特征及结局。
Thyroid. 2011 Apr;21(4):383-9. doi: 10.1089/thy.2010.0331.